HEADER VIRAL PROTEIN 16-JUL-21 7FDK TITLE SARS-COV-2 SPIKE RBDMACSP36 BINDING TO MACE2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACE-RELATED CARBOXYPEPTIDASE; COMPND 5 EC: 3.4.17.23,3.4.17.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: SPIKE PROTEIN S1; COMPND 9 CHAIN: E; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: ACE2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 10 2; SOURCE 11 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 12 ORGANISM_TAXID: 2697049; SOURCE 13 GENE: S, 2; SOURCE 14 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2 SPIKE, MACE2, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR X.WANG,L.CAO REVDAT 2 23-MAR-22 7FDK 1 JRNL REVDAT 1 25-AUG-21 7FDK 0 JRNL AUTH S.SUN,H.GU,L.CAO,Q.CHEN,Q.YE,G.YANG,R.T.LI,H.FAN,Y.Q.DENG, JRNL AUTH 2 X.SONG,Y.QI,M.LI,J.LAN,R.FENG,Y.GUO,N.ZHU,S.QIN,L.WANG, JRNL AUTH 3 Y.F.ZHANG,C.ZHOU,L.ZHAO,Y.CHEN,M.SHEN,Y.CUI,X.YANG,X.WANG, JRNL AUTH 4 W.TAN,H.WANG,X.WANG,C.F.QIN JRNL TITL CHARACTERIZATION AND STRUCTURAL BASIS OF A LETHAL JRNL TITL 2 MOUSE-ADAPTED SARS-COV-2. JRNL REF NAT COMMUN V. 12 5654 2021 JRNL REFN ESSN 2041-1723 JRNL PMID 34580297 JRNL DOI 10.1038/S41467-021-25903-X REMARK 2 REMARK 2 RESOLUTION. 3.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.690 REMARK 3 NUMBER OF PARTICLES : 162615 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7FDK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-JUL-21. REMARK 100 THE DEPOSITION ID IS D_1300023337. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2 SPIKE RBDMACSP36 REMARK 245 -MACE2 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN REMARK 245 DETECTOR TYPE : GATAN K2 BASE (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 SER A 5 REMARK 465 TRP A 6 REMARK 465 LEU A 7 REMARK 465 LEU A 8 REMARK 465 LEU A 9 REMARK 465 SER A 10 REMARK 465 LEU A 11 REMARK 465 VAL A 12 REMARK 465 ALA A 13 REMARK 465 VAL A 14 REMARK 465 THR A 15 REMARK 465 ALA A 16 REMARK 465 ALA A 17 REMARK 465 GLN A 18 REMARK 465 HIS A 616 REMARK 465 HIS A 617 REMARK 465 HIS A 618 REMARK 465 HIS A 619 REMARK 465 HIS A 620 REMARK 465 HIS A 621 REMARK 465 MET E 320 REMARK 465 PHE E 321 REMARK 465 VAL E 322 REMARK 465 PHE E 323 REMARK 465 LEU E 324 REMARK 465 VAL E 325 REMARK 465 LEU E 326 REMARK 465 LEU E 327 REMARK 465 PRO E 328 REMARK 465 LEU E 329 REMARK 465 VAL E 330 REMARK 465 SER E 331 REMARK 465 SER E 332 REMARK 465 HIS E 527 REMARK 465 HIS E 528 REMARK 465 HIS E 529 REMARK 465 HIS E 530 REMARK 465 HIS E 531 REMARK 465 HIS E 532 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 41 O THR E 500 2.08 REMARK 500 OH TYR A 237 O VAL A 485 2.11 REMARK 500 OH TYR A 535 O SER A 538 2.12 REMARK 500 O ILE E 418 N ASP E 420 2.12 REMARK 500 OH TYR A 535 O LYS A 541 2.16 REMARK 500 OD2 ASP E 442 NE ARG E 509 2.18 REMARK 500 O PHE A 504 ND2 ASN A 508 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ILE A 358 C LYS A 359 N 0.215 REMARK 500 LYS A 359 C MET A 360 N 0.199 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ILE A 358 O - C - N ANGL. DEV. = 11.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 53 48.43 -141.57 REMARK 500 ALA A 80 52.66 -91.12 REMARK 500 PRO A 138 2.75 -66.14 REMARK 500 GLU A 145 -179.79 -68.16 REMARK 500 PRO A 146 59.08 -61.98 REMARK 500 MET A 152 45.89 -92.76 REMARK 500 ALA A 153 -41.35 -131.01 REMARK 500 PRO A 253 44.83 -79.08 REMARK 500 PRO A 284 -170.22 -64.80 REMARK 500 PHE A 285 120.12 -36.98 REMARK 500 ALA A 286 53.03 -93.50 REMARK 500 ASP A 292 147.64 -172.04 REMARK 500 HIS A 353 13.53 53.89 REMARK 500 TYR A 385 31.44 -95.92 REMARK 500 PRO A 389 47.78 -75.56 REMARK 500 PHE A 390 -9.93 65.70 REMARK 500 LEU A 392 61.96 -100.92 REMARK 500 LEU A 444 4.19 -64.24 REMARK 500 SER A 507 46.47 -88.79 REMARK 500 ASN A 508 13.30 -143.53 REMARK 500 PRO E 337 21.97 -73.86 REMARK 500 ALA E 352 31.28 -91.06 REMARK 500 ALA E 372 13.94 59.28 REMARK 500 PRO E 412 82.04 -69.63 REMARK 500 GLN E 414 115.72 -162.83 REMARK 500 ILE E 418 -84.55 -110.23 REMARK 500 ALA E 419 -25.60 49.26 REMARK 500 ASP E 420 -0.61 -148.25 REMARK 500 LEU E 455 -157.56 -78.75 REMARK 500 PHE E 456 135.91 -37.30 REMARK 500 PHE E 464 -1.44 66.22 REMARK 500 GLU E 516 145.44 -170.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 145 PRO A 146 -130.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-31546 RELATED DB: EMDB REMARK 900 SARS-COV-2 SPIKE RBDMACSP36 BINDING TO MACE2 DBREF 7FDK A 1 615 UNP Q8R0I0 ACE2_MOUSE 1 615 DBREF 7FDK E 333 526 UNP P0DTC2 SPIKE_SARS2 333 526 SEQADV 7FDK ALA A 16 UNP Q8R0I0 THR 16 ENGINEERED MUTATION SEQADV 7FDK GLY A 220 UNP Q8R0I0 ASN 220 ENGINEERED MUTATION SEQADV 7FDK HIS A 228 UNP Q8R0I0 ARG 228 ENGINEERED MUTATION SEQADV 7FDK LYS A 309 UNP Q8R0I0 GLN 309 ENGINEERED MUTATION SEQADV 7FDK ASP A 335 UNP Q8R0I0 GLU 335 ENGINEERED MUTATION SEQADV 7FDK GLU A 336 UNP Q8R0I0 PRO 336 ENGINEERED MUTATION SEQADV 7FDK HIS A 616 UNP Q8R0I0 EXPRESSION TAG SEQADV 7FDK HIS A 617 UNP Q8R0I0 EXPRESSION TAG SEQADV 7FDK HIS A 618 UNP Q8R0I0 EXPRESSION TAG SEQADV 7FDK HIS A 619 UNP Q8R0I0 EXPRESSION TAG SEQADV 7FDK HIS A 620 UNP Q8R0I0 EXPRESSION TAG SEQADV 7FDK HIS A 621 UNP Q8R0I0 EXPRESSION TAG SEQADV 7FDK MET E 320 UNP P0DTC2 INITIATING METHIONINE SEQADV 7FDK PHE E 321 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK VAL E 322 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK PHE E 323 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK LEU E 324 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK VAL E 325 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK LEU E 326 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK LEU E 327 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK PRO E 328 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK LEU E 329 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK VAL E 330 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK SER E 331 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK SER E 332 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK ASN E 417 UNP P0DTC2 LYS 417 ENGINEERED MUTATION SEQADV 7FDK HIS E 493 UNP P0DTC2 GLN 493 ENGINEERED MUTATION SEQADV 7FDK TYR E 501 UNP P0DTC2 ASN 501 ENGINEERED MUTATION SEQADV 7FDK HIS E 527 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK HIS E 528 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK HIS E 529 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK HIS E 530 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK HIS E 531 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDK HIS E 532 UNP P0DTC2 EXPRESSION TAG SEQRES 1 A 621 MET SER SER SER SER TRP LEU LEU LEU SER LEU VAL ALA SEQRES 2 A 621 VAL THR ALA ALA GLN SER LEU THR GLU GLU ASN ALA LYS SEQRES 3 A 621 THR PHE LEU ASN ASN PHE ASN GLN GLU ALA GLU ASP LEU SEQRES 4 A 621 SER TYR GLN SER SER LEU ALA SER TRP ASN TYR ASN THR SEQRES 5 A 621 ASN ILE THR GLU GLU ASN ALA GLN LYS MET SER GLU ALA SEQRES 6 A 621 ALA ALA LYS TRP SER ALA PHE TYR GLU GLU GLN SER LYS SEQRES 7 A 621 THR ALA GLN SER PHE SER LEU GLN GLU ILE GLN THR PRO SEQRES 8 A 621 ILE ILE LYS ARG GLN LEU GLN ALA LEU GLN GLN SER GLY SEQRES 9 A 621 SER SER ALA LEU SER ALA ASP LYS ASN LYS GLN LEU ASN SEQRES 10 A 621 THR ILE LEU ASN THR MET SER THR ILE TYR SER THR GLY SEQRES 11 A 621 LYS VAL CYS ASN PRO LYS ASN PRO GLN GLU CYS LEU LEU SEQRES 12 A 621 LEU GLU PRO GLY LEU ASP GLU ILE MET ALA THR SER THR SEQRES 13 A 621 ASP TYR ASN SER ARG LEU TRP ALA TRP GLU GLY TRP ARG SEQRES 14 A 621 ALA GLU VAL GLY LYS GLN LEU ARG PRO LEU TYR GLU GLU SEQRES 15 A 621 TYR VAL VAL LEU LYS ASN GLU MET ALA ARG ALA ASN ASN SEQRES 16 A 621 TYR ASN ASP TYR GLY ASP TYR TRP ARG GLY ASP TYR GLU SEQRES 17 A 621 ALA GLU GLY ALA ASP GLY TYR ASN TYR ASN ARG GLY GLN SEQRES 18 A 621 LEU ILE GLU ASP VAL GLU HIS THR PHE ALA GLU ILE LYS SEQRES 19 A 621 PRO LEU TYR GLU HIS LEU HIS ALA TYR VAL ARG ARG LYS SEQRES 20 A 621 LEU MET ASP THR TYR PRO SER TYR ILE SER PRO THR GLY SEQRES 21 A 621 CYS LEU PRO ALA HIS LEU LEU GLY ASP MET TRP GLY ARG SEQRES 22 A 621 PHE TRP THR ASN LEU TYR PRO LEU THR VAL PRO PHE ALA SEQRES 23 A 621 GLN LYS PRO ASN ILE ASP VAL THR ASP ALA MET MET ASN SEQRES 24 A 621 GLN GLY TRP ASP ALA GLU ARG ILE PHE LYS GLU ALA GLU SEQRES 25 A 621 LYS PHE PHE VAL SER VAL GLY LEU PRO HIS MET THR GLN SEQRES 26 A 621 GLY PHE TRP ALA ASN SER MET LEU THR ASP GLU ALA ASP SEQRES 27 A 621 GLY ARG LYS VAL VAL CYS HIS PRO THR ALA TRP ASP LEU SEQRES 28 A 621 GLY HIS GLY ASP PHE ARG ILE LYS MET CYS THR LYS VAL SEQRES 29 A 621 THR MET ASP ASN PHE LEU THR ALA HIS HIS GLU MET GLY SEQRES 30 A 621 HIS ILE GLN TYR ASP MET ALA TYR ALA ARG GLN PRO PHE SEQRES 31 A 621 LEU LEU ARG ASN GLY ALA ASN GLU GLY PHE HIS GLU ALA SEQRES 32 A 621 VAL GLY GLU ILE MET SER LEU SER ALA ALA THR PRO LYS SEQRES 33 A 621 HIS LEU LYS SER ILE GLY LEU LEU PRO SER ASP PHE GLN SEQRES 34 A 621 GLU ASP SER GLU THR GLU ILE ASN PHE LEU LEU LYS GLN SEQRES 35 A 621 ALA LEU THR ILE VAL GLY THR LEU PRO PHE THR TYR MET SEQRES 36 A 621 LEU GLU LYS TRP ARG TRP MET VAL PHE ARG GLY GLU ILE SEQRES 37 A 621 PRO LYS GLU GLN TRP MET LYS LYS TRP TRP GLU MET LYS SEQRES 38 A 621 ARG GLU ILE VAL GLY VAL VAL GLU PRO LEU PRO HIS ASP SEQRES 39 A 621 GLU THR TYR CYS ASP PRO ALA SER LEU PHE HIS VAL SER SEQRES 40 A 621 ASN ASP TYR SER PHE ILE ARG TYR TYR THR ARG THR ILE SEQRES 41 A 621 TYR GLN PHE GLN PHE GLN GLU ALA LEU CYS GLN ALA ALA SEQRES 42 A 621 LYS TYR ASN GLY SER LEU HIS LYS CYS ASP ILE SER ASN SEQRES 43 A 621 SER THR GLU ALA GLY GLN LYS LEU LEU LYS MET LEU SER SEQRES 44 A 621 LEU GLY ASN SER GLU PRO TRP THR LYS ALA LEU GLU ASN SEQRES 45 A 621 VAL VAL GLY ALA ARG ASN MET ASP VAL LYS PRO LEU LEU SEQRES 46 A 621 ASN TYR PHE GLN PRO LEU PHE ASP TRP LEU LYS GLU GLN SEQRES 47 A 621 ASN ARG ASN SER PHE VAL GLY TRP ASN THR GLU TRP SER SEQRES 48 A 621 PRO TYR ALA ASP HIS HIS HIS HIS HIS HIS SEQRES 1 E 213 MET PHE VAL PHE LEU VAL LEU LEU PRO LEU VAL SER SER SEQRES 2 E 213 THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR SEQRES 3 E 213 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SEQRES 4 E 213 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER SEQRES 5 E 213 ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO SEQRES 6 E 213 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 7 E 213 ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE SEQRES 8 E 213 ALA PRO GLY GLN THR GLY ASN ILE ALA ASP TYR ASN TYR SEQRES 9 E 213 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 10 E 213 ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR SEQRES 11 E 213 ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS SEQRES 12 E 213 PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA SEQRES 13 E 213 GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS SEQRES 14 E 213 TYR PHE PRO LEU HIS SER TYR GLY PHE GLN PRO THR TYR SEQRES 15 E 213 GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 16 E 213 PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY HIS SEQRES 17 E 213 HIS HIS HIS HIS HIS HET NAG A 701 14 HET NAG A 702 14 HET NAG E 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 3(C8 H15 N O6) HELIX 1 AA1 LEU A 20 ASN A 53 1 34 HELIX 2 AA2 GLU A 56 THR A 79 1 24 HELIX 3 AA3 THR A 90 GLN A 101 1 12 HELIX 4 AA4 SER A 109 THR A 129 1 21 HELIX 5 AA5 LEU A 144 LEU A 148 1 5 HELIX 6 AA6 GLU A 150 SER A 155 1 6 HELIX 7 AA7 ASP A 157 ASN A 194 1 38 HELIX 8 AA8 ASP A 198 GLY A 205 1 8 HELIX 9 AA9 GLY A 220 ALA A 231 1 12 HELIX 10 AB1 ILE A 233 TYR A 252 1 20 HELIX 11 AB2 TYR A 279 VAL A 283 5 5 HELIX 12 AB3 VAL A 293 ASN A 299 1 7 HELIX 13 AB4 ASP A 303 VAL A 318 1 16 HELIX 14 AB5 THR A 324 SER A 331 1 8 HELIX 15 AB6 MET A 366 MET A 383 1 18 HELIX 16 AB7 PHE A 400 SER A 411 1 12 HELIX 17 AB8 THR A 414 ILE A 421 1 8 HELIX 18 AB9 ASP A 431 ARG A 465 1 35 HELIX 19 AC1 TRP A 473 VAL A 485 1 13 HELIX 20 AC2 ASP A 499 LEU A 503 5 5 HELIX 21 AC3 ILE A 513 ALA A 533 1 21 HELIX 22 AC4 THR A 548 SER A 559 1 12 HELIX 23 AC5 PRO A 565 GLY A 575 1 11 HELIX 24 AC6 LYS A 582 PHE A 588 1 7 HELIX 25 AC7 PHE A 588 ASN A 599 1 12 HELIX 26 AC8 PRO E 337 ASN E 343 1 7 HELIX 27 AC9 TYR E 365 ASN E 370 1 6 HELIX 28 AD1 SER E 383 LEU E 390 1 8 HELIX 29 AD2 ARG E 403 VAL E 407 5 5 HELIX 30 AD3 SER E 438 SER E 443 1 6 SHEET 1 AA1 2 LYS A 131 CYS A 133 0 SHEET 2 AA1 2 CYS A 141 LEU A 143 -1 O LEU A 142 N VAL A 132 SHEET 1 AA2 2 LEU A 262 PRO A 263 0 SHEET 2 AA2 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 AA3 2 THR A 347 GLY A 352 0 SHEET 2 AA3 2 ASP A 355 LYS A 359 -1 O LYS A 359 N THR A 347 SHEET 1 AA4 4 ASN E 354 ARG E 355 0 SHEET 2 AA4 4 ASN E 394 ILE E 402 -1 O SER E 399 N ASN E 354 SHEET 3 AA4 4 TYR E 508 GLU E 516 -1 O VAL E 512 N ASP E 398 SHEET 4 AA4 4 GLY E 431 ASN E 437 -1 N ILE E 434 O VAL E 511 SHEET 1 AA5 2 LEU E 452 ARG E 454 0 SHEET 2 AA5 2 LEU E 492 SER E 494 -1 O HIS E 493 N TYR E 453 SHEET 1 AA6 2 TYR E 473 GLN E 474 0 SHEET 2 AA6 2 CYS E 488 TYR E 489 -1 O TYR E 489 N TYR E 473 SSBOND 1 CYS A 133 CYS A 141 1555 1555 2.03 SSBOND 2 CYS E 336 CYS E 361 1555 1555 2.03 SSBOND 3 CYS E 480 CYS E 488 1555 1555 2.03 LINK ND2 ASN A 53 C1 NAG A 702 1555 1555 1.43 LINK ND2 ASN A 546 C1 NAG A 701 1555 1555 1.43 LINK ND2 ASN E 343 C1 NAG E 601 1555 1555 1.45 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000